Petefészekrák: vizsgálatok itt: Spanyolország
90 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 17.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleA Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
- Where
- Barcelona, Madrid
- Életkor
- 18 év and over
- People
- 248 worldwide
- Run by
- Terremoto Biosciences Inc.
See details and how to joinNCT07109726 - 2/3. fázisFut, nem toborozA Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- Where
- Badalona, Barcelona, Jaén, Madrid, Pamplona, Valencia
- Életkor
- 18 év and over
- People
- 860 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06161025 · EU 2023-507914-28-00 - 2. fázisTaking peopleA Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Where
- Barcelona, Madrid, Málaga, Seville, Valencia
- Életkor
- 18 év and over
- People
- 740 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00 - 1/2. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Barcelona, L'Hospitalet de Llobregat, Madrid, Sevilla
- Életkor
- 18 év and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - 2. fázisTaking peopleA Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Platinum-based Chemotherapy in completeLy debUlked Advanced HRDpositive High-grade Ovarian Cancer patientS in First Line Therapy
- Where
- Alicante, Granada, Lugo, Madrid, Manresa, Reus, Sevilla, Valencia
- Életkor
- 18 év and over
- People
- 640 worldwide
- Run by
- North Eastern German Society of Gynaecological Oncology
See details and how to joinNCT05460000 · EU 2022-502559-69-01 - 1/2. fázisTaking peopleA Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Where
- A Coruña, Badalona, Barcelona, Córdoba, Elche, El Palmar, Girona, Lleida, Madrid, Málaga, Pamplona, Pozuelo de Alarcón, Rioja, Sabadell, Santander, Seville, Valencia, Zaragoza
- Életkor
- 18 év and over
- People
- 542 worldwide
- Run by
- Artios Pharma Ltd
See details and how to joinNCT04657068 - 3. fázisNot yet taking people in SpanyolországTorvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer
- Where
- A Coruña, Barakaldo, Barcelona, Granollers, Madrid
- Életkor
- 18 év and over
- People
- 600 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07816666 · EU 2026-526776-23-00 - 1/2. fázisTaking peopleA Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
- Where
- Barcelona, Logroño, Madrid, Pozuelo de Alarcón
- Életkor
- 18 év and over
- People
- 245 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT07186842 · EU 2025-522613-26-00 - 3. fázisBefejeződöttStudy to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- Where
- Badalona, Barcelona, Madrid, Málaga, Oviedo, Palma, Pamplona, Sabadell, Sevilla, Valencia, Vitoria
- Életkor
- 18 év and over
- People
- 466 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT07214779 · EU 2025-522748-42-00 - 1. fázisTaking peopleStudy to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
- Where
- Badalona, Barcelona, Madrid, Málaga, Pamplona, Zaragoza
- Életkor
- 18 év and over
- People
- 325 worldwide
- Run by
- AbbVie
See details and how to joinNCT06084481 · EU 2023-506227-29-00 - 1/2. fázisTaking peopleA Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
- Where
- Barcelona, L'Hospitalet de Llobregat, Madrid, Málaga, Pamplona
- Életkor
- 18 év and over
- People
- 460 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05123482 · EU 2022-502759-70-01 - 2. fázisTaking peopleA Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
- Where
- A Coruña, Barcelona, Donostia, Girona, Las Palmas de Gran Canaria, Madrid, Majadahonda, Santander, Sevilla, Valencia, Zaragoza
- Életkor
- 18 év and over
- People
- 400 worldwide
- Run by
- AbbVie
See details and how to joinNCT07059845 · EU 2025-521606-18-00 - 1. fázisTaking peopleA Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
- Where
- Barcelona, Madrid, Majadahonda
- Életkor
- 18 év and over
- People
- 285 worldwide
- Run by
- AbbVie
See details and how to joinNCT07278336 · EU 2025-522209-40-00 - 1. fázisTaking peoplePhase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
- Where
- Barcelona, Madrid, Pamplona
- Életkor
- 15 év and over
- People
- 282 worldwide
- Run by
- Xencor, Inc.
See details and how to joinNCT06276491 - No phaseNot yet taking people in SpanyolországCombined Program of Supervised Physical Exercise and Nutritional Counseling in Ovarian Cancer Patients on Frontline Maintenance Treatment With PARP Inhibitors
- Where
- Madrid
- Életkor
- 18 év and over
- People
- 32
- Run by
- Oncare Madrid
See details and how to joinNCT06139783 - 1/2. fázisTaking peopleStudy of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
- Where
- A Coruña, Barcelona, Málaga, Pozuelo de Alarcón, Sant Cugat del Vallès, Sevilla
- Életkor
- 18 év to 130 év
- People
- 695 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05417594 · EU 2023-504984-17-00 - 1/2. fázisTaking peoplePhase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
- Where
- Barcelona, Madrid, Málaga
- Életkor
- 18 év to 130 év
- People
- 622 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05797168 · EU 2022-502576-23-00 - 1/2. fázisTaking peopleThe Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Where
- Barcelona, Madrid, Rioja, Valencia
- Életkor
- 12 év and over
- People
- 300 worldwide
- Run by
- PMV Pharmaceuticals, Inc
See details and how to joinNCT04585750 - 1. fázisTaking peopleDrug-drug Interaction Study With AZD5335 and Itraconazole in Participants With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- Where
- Barcelona, Logrono, Madrid
- Életkor
- 18 év and over
- People
- 32 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07402915 · EU 2025-522731-34-00 - 2/3. fázisTaking peopleA clinical study of MK-5684 in people with certain solid tumors (MK-5684-015)
- Where
- A Coruña, L'Hospitalet de Llobregat, Madrid, Pozuelo de Alarcón
- Életkor
- 18 év and over
- People
- 22
- Run by
- Merck Sharp & Dohme LLC
See details and how to join2024-519563-18-00 - 1/2. fázisTaking peopleStudy of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
- Where
- Badalona, Barcelona, Girona, Madrid, Santiago de Compostela
- Életkor
- 18 év and over
- People
- 890 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT03564340 · EU 2024-510783-23-00 - 1/2. fázisTaking peopleA Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
- Where
- Girona, Madrid, Santiago de Compostela
- Életkor
- 18 év and over
- People
- 612 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT04590326 · EU 2022-501904-83-00 - 2. fázisTaking peopleStudy of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Where
- Barcelona, Córdoba, Madrid, Málaga, Sevilla
- Életkor
- 18 év to 130 év
- People
- 454 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05489211 · EU 2023-509436-26-00 - 1/2. fázisTaking peopleStudy of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Where
- Barcelona, Madrid, Pamplona, Seville, Valencia, Zaragoza
- Életkor
- 18 év and over
- People
- 534 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT06128551 - 1. fázisTaking peopleEvaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Where
- Barcelona, Madrid, Piqueras, Seville
- Életkor
- 18 év and over
- People
- 540 worldwide
- Run by
- SystImmune Inc.
See details and how to joinNCT05983432